Patent details

EP2396333 Title: TRIAZOLOÖ4,3-BÜPYRIDAZINE DERIVATIVES AND THEIR USES FOR PROSTATE CANCER

Basic Information

Publication number:
EP2396333
PCT Application Number:
PCT/GB/2010/050191
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP107039455
PCT Publication Number:
WO/2010/092371
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TRIAZOLOÖ4,3-BÜPYRIDAZINE DERIVATIVES AND THEIR USES FOR PROSTATE CANCER
French Title of Invention:
DÉRIVÉS DE TRIAZOLOÖ4,3-BÜPYRIDAZINE ET LEURS UTILISATIONS CONTRE LE CANCER DE LA PROSTATE
German Title of Invention:
-
SPC Number:

Dates

Filing date:
08/02/2010
Grant date:
03/07/2013
EP Publication Date:
03/07/2013
PCT Publication Date:
19/08/2010
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/12/2011
EP B1 Publication Date:
03/07/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/02/2014
Expiration date:
08/02/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/02/2010
 
 

Name:
AstraZeneca AB
Address:
-, 151 85 Södertälje, Sweden (SE)

Inventor

1

Name:
RAO KORUPOJU Srinivasa
Address:
India (IN)

2

Name:
TUMMA Harikrishna
Address:
India (IN)

3

Name:
RABOW Alfred, Arthur
Address:
United Kingdom (GB)

4

Name:
BRADBURY Robert, Hugh
Address:
United Kingdom (GB)

5

Name:
CARR Gregory, Richard
Address:
United Kingdom (GB)

Priority

1

Priority Number:
151221 P
Priority Date:
10/02/2009
Priority Country:
United States (US)

2

Priority Number:
187766 P
Priority Date:
17/06/2009
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 487/04;
Filing date Document type Number of pages